Company intelligence / Profile preview

GMT Fine Chemicals

Couvet, Neuchâtel, Switzerland

Ownership: Private
Employees: ~40
Development stage: Other

Overview

GMT Fine Chemicals SA is a Swiss contract development and manufacturing organization (CDMO) focused on the production of active pharmaceutical ingredients (APIs). Established in 1998 in Couvet, Switzerland, the company specializes in small molecule chemical synthesis and process development. GMT provides a range of services from laboratory-scale development to industrial-scale commercial manufacturing under cGMP conditions. Their facilities are regularly inspected by Swissmedic and the FDA, ensuring compliance with international quality standards for the global pharmaceutical market.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on GMT Fine Chemicals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GMT Fine Chemicals.

Explore the full profile